7.28新台幣0.02(0.27%)
2023/01/17更新
績效 / 1月1.89%
3月3.7%
1年10.78%
晨星評等-
淨值走勢
基金總覽
基金規模1,050.69百萬截至 2022-12-31
持股明細 / 風險評估
- 1.美國82.91%
- 2.新興亞洲4.52%
- 3.日本2.79%
- 4.已開發亞洲1.24%
- 5.中東0.92%
- 1.健康護理92.26%
- 2.基本物料0.38%
- 3.周期性消費0.31%
- 1.Johnson & Johnson6.23%
- 2.UnitedHealth Group Inc6.00%
- 3.Eli Lilly and Co5.72%
- 4.Merck & Co Inc4.20%
- 5.Regeneron Pharmaceuticals Inc4.15%
- 1.美國82.91%
- 2.新興亞洲4.52%
- 3.日本2.79%
- 4.已開發亞洲1.24%
- 5.中東0.92%
- 1.Johnson & Johnson6.23%
- 2.UnitedHealth Group Inc6.00%
- 3.Eli Lilly and Co5.72%
- 4.Merck & Co Inc4.20%
- 5.Regeneron Pharmaceuticals Inc4.15%
- 1.健康護理92.26%
- 2.基本物料0.38%
- 3.周期性消費0.31%